SCHEMBL23939751

SCHEMBL23939751

CCOc1ccc(F)c(C)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
KDM1A O60341 2/20 0.38
ALDH1A1 P00352 4/20 0.37
ESR1 P03372 1/20 0.37
HTT P42858 1/20 0.37
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
TUBB1 Q9H4B7 1/20 0.36
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28353697 0.82 ALDH1A1 (0.46) L3MBTL1KDM1AALDH1A1HTTMAPT
SCHEMBL10522836 0.80 ESR1 (0.46) ALDH1A1ESR1HTTMAPTPDE4A
SCHEMBL13125478 0.80 L3MBTL1 (0.43) L3MBTL1KDM1AALDH1A1HTTMAPT
SCHEMBL1008554 0.78 L3MBTL1 (0.42) L3MBTL1KDM1AALDH1A1HTTCYP1A2
SCHEMBL13696494 0.76 L3MBTL1 (0.43) L3MBTL1KDM1AALDH1A1HTTMAPT
SCHEMBL4015318 0.76 L3MBTL1 (0.56) L3MBTL1ALDH1A1MAPTNPSR1CYP1A2
SCHEMBL453334 0.75 ALDH1A1 (0.45) L3MBTL1ALDH1A1HTTCYP2C19HPGD
SCHEMBL24240291 0.73 L3MBTL1 (0.47) L3MBTL1KDM1AALDH1A1HTTMAPT
SCHEMBL13696415 0.72 L3MBTL1 (0.56) L3MBTL1ALDH1A1MAPTNPSR1CYP1A2
SCHEMBL21823758 0.72 TSHR (0.39) L3MBTL1ALDH1A1MAPTCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3251678-B1 BENZOXABOROLE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS ANACOR PHARMACEUTICALS INC (US) 2021-10-20 EP disclosed